Case Study Next Week: The Plan Will Change... Then What?


Hi!

We spend a lot of time in comms planning for what we think is going to happen: building strategies, preparing for milestones, pressure-testing scenarios, and trying to anticipate what could change along the way.

And then the plan changes. Or a scenario we didn't anticipate pops up.

Sometimes it’s a small adjustment. Other times, a new development changes the people involved, the priorities, the timing, or the decision itself. The job becomes figuring out what still holds, what needs to move, and how to help the organization make the "right" call.

That’s exactly what Kim Fox, Head of Corporate Communications & Patient Advocacy at Legend Biotech, will explore as she closes Day 2 (October 7th) of our Virtual Biopharma Comms Forum, Owning the Outcome.

🎤 Case Study: Leading Communications Through Constant Flux With Trust, Influence, and Agility

Wednesday, October 7th, 2026 @ 3:30 p.m. ET
Location: Zoom

When Kim joined Legend Biotech less than a year ago, she quickly found herself navigating a dense stretch of company activity. Major data presentations at ASCO and EHA, global media engagement, and leadership transitions were all unfolding while she was still learning the organization, building relationships, and figuring out how decisions really got made.

Concepts Kim will take us through:

  • Building credibility quickly when you’re still learning the organization and the people around you are learning how you operate.
  • Knowing what to plan tightly and what to leave flexible when circumstances are likely to change.
  • Influencing decisions you don’t own, especially when leaders bring different perspectives, priorities, or levels of familiarity with communications.
  • Reprioritizing in real time when unexpected developments suddenly compete with planned work for attention and resources.
  • Extending communications’ impact by building partnerships and shared ownership across the organization instead of relying only on the formal comms team.
  • Leading through ambiguity with curiosity, including how asking better questions can help you understand what’s really driving a decision, surface what may be missing, and find a more productive path forward.

This last piece is one I’m especially looking forward to you all hearing about from Kim. She's developed a practical way of questioning her way through moments where the answer isn’t immediately clear, including understanding what’s at stake, what different people are bringing into the room, and what communications can contribute.

About Kim:

Kim brings more than 30 years of healthcare communications experience across pharmaceutical, biotech, media, and public relations organizations. Before joining Legend Biotech, she was Vice President of Communications at Milestone Pharmaceuticals, where she led corporate, product, and investor communications. Her career has also included leadership roles at Bristol Myers Squibb, Johnson & Johnson, Everyday Health, Sanofi, and Novartis.

Register for one or both days of T2B's Virtual Forum

DAY 1: Tuesday, October 6th | 10:30 a.m.-1:45 p.m. ET
​
REGISTER FOR DAY 1​

DAY 2: Wednesday, October 7th | 2-4 p.m. ET
​
REGISTER FOR DAY 2​

T2B Pro and Student members can attend free as part of their membership. T2B Basic members can register for $275 per day.

Kim's case study will close out this year’s Forum, and I think it’s a fitting way to end two days centered on Owning the Outcome: with a real example of what it looks like when communicators have to keep adjusting, keep influencing, and keep moving the organization forward even when the conditions around them are changing.

Have a good weekend, and see you next week!

Lynnea

T2B Monthly

Read more from T2B Monthly

Hi! If your expertise lies in digital and social media and you're passionate about advancing the industry-wide discourse here, please consider applying for T2B's Digital & Social Media Roundtable by this Monday, November 9th! Returning for its second year, the roundtable brings together biopharma communicators to tackle some of the most pressing questions in digital and social strategy: making complex science accessible and credible, navigating regulatory and compliance considerations,...

Hi! A quick reminder that our next press panel is tomorrow, brought to us by T2B's Media Minds Roundtable. Drew Armstrong (Endpoints News) and Angus Liu (Fierce Pharma) will join to talk about the stories they're following involving China’s growing role in global biopharma, and the issues they expect will shape coverage in 2027. From cross-border licensing and drug discovery to geopolitical tensions, investment, and supply chains, we'll dig into how journalists are navigating the competing...

Hi! Sometimes being successful as a communicator means … nothing actually happens. An emerging issue never becomes a crisis, a major organizational change unfolds without confusion, or a potentially problematic decision is reconsidered before it creates reputational risk. Our upcoming November Comm Convo will be a discussion about recognizing and articulating a part of our profession's value that often goes unnoticed – precisely because we've done our jobs well. We’ll address the challenge...